Allyson Small

Views & Analysis

Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result.

News

As it waits for an FDA decision on one non-opioid pain drug, Viatris has its eye on two more, via a takeover bid for Pacira BioSciences.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.